Issam Mardini
Emirates Hospitals, UAE
Received Date: 2022-09-07 | Accepted Date: 2022-09-14 | Published Date: 2022-09-25

Abstract

Regenerative cell therapies may present multiple advantages to clinicians and patients who are looking to improve patient outcomes. These advantages could be obtained through multiple therapeutic modules, Since started this type of treatment on 2006 by injecting PRP directly, where it was needed then gradually started to widen the scope of such therapy by injecting bone marrow extract which also gave as good results as the PRP. In 2014, gradually started to add to such treatment the purified fat extract and in experience added a wider scope for the treating conditions as well as a far better results from the PRP and finally for the last few years also added the stem cells therapy extracted from the fat tissue which also added a valuable and effective treatment for managing a lot musculoskeletal cases. In addition to the effective treatment and good results actually, there is a significantly reduced risk of rejection or immune response using autologous biologics as compared to alternative treatment options. Also, there is minimal risk of allergic reactions or tissue rejection. The autologous regenerative therapy uses the normal regeneration and repair processes of the human body. From long experience, would like to emphasis that Patients or conditions that are most likely to respond to autologous, biologic-based products have not yet been internationally characterized. Therefore, clinical success depends on several factors including diagnosis, the severity of condition being treated, patient age and comorbidities. In this talk, a journey explaining clinical experience, the way regenerative therapy was used and managed and the success that achieved during this journey has been presented.